Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Once confined to diabetes management, these drugs are now leading a new era of metabolic care
Instead of mimicking gut hormones like GLP-1 medications or following a daily weight loss injection plan, it targets pathways that regulate fat storage, energy expenditure, and insulin sensitivity
Looking ahead, I expect continued development of products and menu items that are smaller in portion size, aligning with reduced appetites, and fortified with protein and other nutrients that must be maintained as overall consumption declines
GLP-1, GIP and GCG (each at 1 nmol/l) enhanced GSIS by ~eightfold, ~fivefold and ~fourfold, respectively, whereas the triagonist (1 nmol/l) elicited an ~11-fold increase (Fig
.webp)
